Anti‐PD‐1/Her2 Bispecific Antibody IBI315 Enhances the Treatment Effect of Her2‐Positive Gastric Cancer through Gasdermin B‐Cleavage Induced Pyroptosis
Abstract The majority of patients with human epidermal growth factor receptor 2 (Her2)‐positive gastric cancer develop refractory to Her2‐targeted therapy, where upregulation of immune checkpoints plays an essential role. Herein, a recombinant fully human IgG1 bispecific antibody IBI315 targeting bo...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wiley
2023-10-01
|
| Серии: | Advanced Science |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1002/advs.202303908 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
